UK Company Championing Near-Patient Testing for Therapeutic Differentiation

Abingdon Health is championing the use of cost-effective near-patient testing to aid the therapeutic market share and profitability ambitions of pharmaceutical companies in an industry that is set for increased competition.
 
 
Spread the Word
Listed Under

Tag:
* Pharmaceutical

Industry:
* Medical

Location:
* York - Yorkshire - England

YORK, England - Aug. 6, 2019 - PRLog -- Analysts say that by 2020 $25 billion of $100 billion in biologics sales will be in this area (KPMG 2015). So, pharmaceutical companies will need to strategically plan to reinforce therapeutic differentiation and avoid missing any significant market opportunities. But how can they do this?

The use of near-patient test and mHealth rapid diagnostic technology is a solution for aiding therapeutic differentiation: intuitive in-clinic, home or over-the-counter (OTC) drug activity monitoring methods for therapy guidance being the main differentiators.

As an experienced contract manufacturing organisation (CMO), Abingdon Health is helping global pharmaceutical partners cement their therapeutic market ambitions through the use of near-patient lateral flow immunoassays.

These technologies offer a variety of testing and monitoring solutions owing to their flexibility in being able to offer qualitative, semi-quantitative or quantitative results and detect different markers in a variety of sample types.

Greater Therapeutic Up-Take Owing To Intuitive Drug Marker Monitoring

A big concern for clinicians and patients alike is slow results delivery and any subsequent delay in drug therapy guidance owing to labour intensive laboratory monitoring methods.

The competitive advantage and growth opportunities for the pharmaceutical industry lie in greater uptake in a therapeutic, or a biosimilar for that matter, owing to the quick and intuitive way in which a drug can be monitored.

Policymakers are more likely to choose the use of approved drugs if the monitoring methods aids the concerns of busy and financially-stretched primary care services, at the same time as addressing patient anxiety.

See How We Can Aid Your Therapeutic Differentiation Strategy

Learn how Abingdon Health's value for money services could deliver a quality, complementary near-patient test to aid your therapeutic differentiation strategy. Download our brochure at https://www.abingdonhealth.com/cs-resources/pharmaceutical-industry-brochure/.

Contact
***@abingdonhealth.com
1904406082
End
Email:***@abingdonhealth.com Email Verified
Tags:Pharmaceutical
Industry:Medical
Location:York - Yorkshire - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Abingdon Health News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share